FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225252110> ?p ?o ?g. }

• W4225252110 endingPage "289" @default.
• W4225252110 startingPage "282" @default.
• W4225252110 abstract "Wuzi-Yanzong-Wan (WZYZW) is a classic prescription for male infertility. Our previous investigation has demonstrated that it can inhibit sperm apoptosis via affecting mitochondria, but the underlying mechanisms are unclear. The purpose of the present study was to explore the actions of WZYZW on mitochondrial permeability transition pore (mPTP) in mouse spermatocyte cell line (GC-2 cells) opened by atractyloside (ATR). At first, WZYZW-medicated serum was prepared from rats following oral administration of WZYZW for 7 days. GC-2 cells were divided into control group, model group, positive group, as well as 5%, 10%, 15% WZYZW-medicated serum group. Cyclosporine A (CsA) was used as a positive control. 50 μmol·L-1 ATR was added after drugs incubation. Cell viability was assessed using CCK-8. Apoptosis was detected using flow cytometry and TUNEL method. The opening of mPTP and mitochondrial membrane potential (MMP) were detected by Calcein AM and JC-1 fluorescent probe respectively. The mRNA and protein levels of voltage-dependent anion channel 1 (VDAC1), cyclophilin D (CypD), adenine nucleotide translocator (ANT), cytochrome C (Cyt C), caspase 3, 9 were detected by RT-PCR (real time quantity PCR) and Western blotting respectively. The results demonstrated that mPTP of GC-2 cells was opened after 24 hours of ATR treatment, resulting in decreased MMP and increased apoptosis. Pre-protection with WZYZ-medicated serum and CsA inhibited the opening of mPTP of GC-2 cells induced by ATR associated with increased MMP and decreased apoptosis. Moreover, the results of RT-qPCR and WB suggested that WZYZW-medicated serum could significantly reduce the mRNA and protein levels of VDAC1 and CypD, Caspase-3, 9 and CytC, as well as a increased ratio of Bcl/Bax. However, ANT was not significantly affected. Therefore, these findings indicated that WZYZW inhibited mitochondrial mediated apoptosis by attenuating the opening of mPTP in GC-2 cells. WZYZW-medicated serum inhibited the expressions of VDAC1 and CypD and increased the expression of Bcl-2, which affected the opening of mPTP and exerted protective and anti-apoptotic effects on GC-2 cell induced by ATR." @default.
• W4225252110 created "2022-05-04" @default.
• W4225252110 creator A5006500153 @default.
• W4225252110 creator A5020415816 @default.
• W4225252110 creator A5047297187 @default.
• W4225252110 creator A5055726483 @default.
• W4225252110 creator A5061391281 @default.
• W4225252110 creator A5076699095 @default.
• W4225252110 creator A5087059542 @default.
• W4225252110 date "2022-04-01" @default.
• W4225252110 modified "2023-10-13" @default.
• W4225252110 title "Study on the mechanism of Wuzi-Yanzong-Wan-medicated serum interfering with the mitochondrial permeability transition pore in the GC-2 cell induced by atractyloside" @default.
• W4225252110 cites W2099727757 @default.
• W4225252110 cites W2100925161 @default.
• W4225252110 cites W2234450242 @default.
• W4225252110 cites W2263451180 @default.
• W4225252110 cites W2749880090 @default.
• W4225252110 cites W2759298771 @default.
• W4225252110 cites W2789907882 @default.
• W4225252110 cites W2802111803 @default.
• W4225252110 cites W2898921505 @default.
• W4225252110 cites W2904483354 @default.
• W4225252110 cites W2955973200 @default.
• W4225252110 cites W2960686802 @default.
• W4225252110 cites W2964942974 @default.
• W4225252110 cites W2979752737 @default.
• W4225252110 cites W2995322499 @default.
• W4225252110 cites W2996239439 @default.
• W4225252110 cites W2998735461 @default.
• W4225252110 cites W3005749712 @default.
• W4225252110 cites W3009806530 @default.
• W4225252110 cites W3049738088 @default.
• W4225252110 cites W3081872289 @default.
• W4225252110 cites W3097215886 @default.
• W4225252110 cites W4211187845 @default.
• W4225252110 doi "https://doi.org/10.1016/s1875-5364(22)60153-5" @default.
• W4225252110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35487598" @default.
• W4225252110 hasPublicationYear "2022" @default.
• W4225252110 type Work @default.
• W4225252110 citedByCount "2" @default.
• W4225252110 countsByYear W42252521102023 @default.
• W4225252110 crossrefType "journal-article" @default.
• W4225252110 hasAuthorship W4225252110A5006500153 @default.
• W4225252110 hasAuthorship W4225252110A5020415816 @default.
• W4225252110 hasAuthorship W4225252110A5047297187 @default.
• W4225252110 hasAuthorship W4225252110A5055726483 @default.
• W4225252110 hasAuthorship W4225252110A5061391281 @default.
• W4225252110 hasAuthorship W4225252110A5076699095 @default.
• W4225252110 hasAuthorship W4225252110A5087059542 @default.
• W4225252110 hasConcept C134018914 @default.
• W4225252110 hasConcept C13591479 @default.
• W4225252110 hasConcept C137183658 @default.
• W4225252110 hasConcept C153911025 @default.
• W4225252110 hasConcept C185592680 @default.
• W4225252110 hasConcept C190283241 @default.
• W4225252110 hasConcept C196795494 @default.
• W4225252110 hasConcept C2778674702 @default.
• W4225252110 hasConcept C28859421 @default.
• W4225252110 hasConcept C29311851 @default.
• W4225252110 hasConcept C31573885 @default.
• W4225252110 hasConcept C513476851 @default.
• W4225252110 hasConcept C55493867 @default.
• W4225252110 hasConcept C75385678 @default.
• W4225252110 hasConcept C86803240 @default.
• W4225252110 hasConcept C98274493 @default.
• W4225252110 hasConceptScore W4225252110C134018914 @default.
• W4225252110 hasConceptScore W4225252110C13591479 @default.
• W4225252110 hasConceptScore W4225252110C137183658 @default.
• W4225252110 hasConceptScore W4225252110C153911025 @default.
• W4225252110 hasConceptScore W4225252110C185592680 @default.
• W4225252110 hasConceptScore W4225252110C190283241 @default.
• W4225252110 hasConceptScore W4225252110C196795494 @default.
• W4225252110 hasConceptScore W4225252110C2778674702 @default.
• W4225252110 hasConceptScore W4225252110C28859421 @default.
• W4225252110 hasConceptScore W4225252110C29311851 @default.
• W4225252110 hasConceptScore W4225252110C31573885 @default.
• W4225252110 hasConceptScore W4225252110C513476851 @default.
• W4225252110 hasConceptScore W4225252110C55493867 @default.
• W4225252110 hasConceptScore W4225252110C75385678 @default.
• W4225252110 hasConceptScore W4225252110C86803240 @default.
• W4225252110 hasConceptScore W4225252110C98274493 @default.
• W4225252110 hasFunder F4320321001 @default.
• W4225252110 hasFunder F4320335467 @default.
• W4225252110 hasIssue "4" @default.
• W4225252110 hasLocation W42252521101 @default.
• W4225252110 hasLocation W42252521102 @default.
• W4225252110 hasOpenAccess W4225252110 @default.
• W4225252110 hasPrimaryLocation W42252521101 @default.
• W4225252110 hasRelatedWork W141420358 @default.
• W4225252110 hasRelatedWork W1593734817 @default.
• W4225252110 hasRelatedWork W2056106575 @default.
• W4225252110 hasRelatedWork W2063136681 @default.
• W4225252110 hasRelatedWork W2352815005 @default.
• W4225252110 hasRelatedWork W2370539394 @default.
• W4225252110 hasRelatedWork W2756204538 @default.
• W4225252110 hasRelatedWork W2769319788 @default.
• W4225252110 hasRelatedWork W2917604170 @default.
• W4225252110 hasRelatedWork W932784800 @default.

• next